RLMD

Relmada Therapeutics, Inc. $4.44 1M -6.5% 3M -33.2% YTD +1.6% as of 2026-09-14
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.2%
Next 1 week
+0.2%
Next 1 month
-0.8%
Seasonality
Mildly positive window
Next 30 days (to Oct 15): +1.3% median, 55% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 66
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.55%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.81 -0.8%
$5M/day volume 103% volatility +192% 1-year
52-week range · 46% of the way up · -44% from the high
$1.45$8.00

Congressional trades in RLMD Full tracker →

1 member · 1 buys / 1 sells · $2K–$30K disclosed · latest filing Jan 20, 2023.

SELL CJ Christopher L. Jacobs · traded Dec 12, 2022 $1K–$15K
BUY CJ Christopher L. Jacobs · traded Nov 8, 2022 $1K–$15K

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.